Gain insights about health economics and outcomes from Phase II/III through post-launch.
Learn MoreGain insights about health economics and outcomes from Phase II/III through post-launch.
Learn MoreAlign RWD about patients, providers, payers, diseases, and outcomes to evidence and strategy.
Learn MoreAccelerate insights, bolster ROI, master markets, and optimize clinical trials.
Learn MoreEvidence generation requires real-world data (RWD), specialized experience, and deep expertise across various health and life science sectors. We help you gain insights in HEOR from Phase II/III through post-launch to support product value.
Learn the needs and challenges of high burden segments to identify the most appropriate patient population for your drug, and support early-stage evidence and pre-launch commercialization planning.
Gain comprehensive insights about disease landscape, comorbidities, treatment utilization, and specialty providers to drive future study design and evidence planning.
Ensure the benefits, risks, value, and potential of products from commercial, Medicaid, and Medicare claims to support forecasting and economic modeling.
Measure the impact of a disease to inform healthcare interventions, treatments, policies, and priority settings, with publication opportunities to support communications with payers and policy makers.
Drive strategic decision-making, shape future study design, and support value communications with real-world evidence (RWE) focused on practical treatment utilization rates.
Generate evidence about adherence and impact on serious clinical outcomes for specific subsets of patients, including mortality for those with rare or chronic conditions.
Prioritize patient access to therapy, negotiate contracts for improved formulary status, or realize cost savings with utilization of a particular therapy over standard of care.
With STATinMED RWD Custom Registry you have information at your fingertips to take immediate action and make better, faster decisions that will improve patient access and outcomes.
Available patient-level measures include:
A successful market access strategy requires comprehensive data insights for all stages of the product lifecycle. We help you develop strategies for product launch through commercialization.
Clinical Eligibility through Real World Data
Allow data-driven decision-making and account prioritization based on the addressable market.
Gain Real World HCO-HCP Insights
Identify clinically appropriate Healthcare Organizations (HCO) and Healthcare Providers (HCP) with high opportunities to support field teams.
Measuring Opportunity Loss
Discover the impact of utilization management practices on patient access and adherence to therapy to support discussions on value-based care.
Gain Competitive Indication Share
Gain indication-specific market share within an account to support contract negotiations.
Prioritize Payer-Provider Insights
Prioritize Healthcare Providers in a complex market based on their share of patients with favorable access to a newly launched therapy.
To transform the future of healthcare, real-world data (RWD) analysis is the gold standard for decision-making—but do you have access to it when you need it?
Get timely and actionable insights delivered on a regular basis from our analysts using robust, de-identified all-payer medical and pharmacy claims data for fast integration to support your business needs.
We have breadth and depth with real-world data insights that are foremost in the Health Economics and Outcomes industry based on hundreds of combined experience years.
Meet Our LeadersWe carefully listen and leverage more data from more sources in less time, to align business needs for better, faster decisions, customized solutions, and successful partnerships.
Partner with UsOur advisory and linkage services provide opportunities to focus the research approach and tailor data needs, analyzing retrospectively while capturing prospectively.
Maximize RWD and RWEWe help healthcare and life science companies understand real-world evidence to best support strategic positioning, solve problems with confidence, and maximize value.
Read Our BlogWith >1000 peer-reviewed publications in dozens of therapeutic areas, our writing and editing team ensures abstracts, posters, manuscripts, and presentations reveal value.
See Our PublicationsWe meticulously manage projects across three data phases, Discover, Develop, Deliver, with seamless quality, agility, and execution every step of the way.
Get In Touch with UsOur approach and insights are foremost in the industry based on hundreds of combined
experience years and >1000 peer-reviewed publications in dozens of therapeutic areas.